Suppr超能文献

纤溶酶原激活物抑制剂-1 的综述及其(病理)生理学作用:靶向还是不靶向?

A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?

机构信息

Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, B-3000 Leuven, Belgium.

出版信息

Int J Mol Sci. 2021 Mar 8;22(5):2721. doi: 10.3390/ijms22052721.

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of plasminogen activators (PAs) and is therefore an important inhibitor of the plasminogen/plasmin system. Being the fast-acting inhibitor of tissue-type PA (tPA), PAI-1 primarily attenuates fibrinolysis. Through inhibition of urokinase-type PA (uPA) and interaction with biological ligands such as vitronectin and cell-surface receptors, the function of PAI-1 extends to pericellular proteolysis, tissue remodeling and other processes including cell migration. This review aims at providing a general overview of the properties of PAI-1 and the role it plays in many biological processes and touches upon the possible use of PAI-1 inhibitors as therapeutics.

摘要

纤溶酶原激活物抑制剂-1(PAI-1)是纤溶酶原激活物(PAs)的主要生理性抑制剂,因此也是纤溶酶原/纤溶系统的重要抑制剂。作为组织型 PA(tPA)的快速作用抑制剂,PAI-1 主要减弱纤维蛋白溶解。通过抑制尿激酶型 PA(uPA)以及与生物配体如 vitronectin 和细胞表面受体相互作用,PAI-1 的功能扩展到细胞周蛋白水解、组织重塑和其他过程,包括细胞迁移。本综述旨在概述 PAI-1 的特性及其在许多生物学过程中的作用,并探讨 PAI-1 抑制剂作为治疗剂的可能用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acfc/7962805/d980ddb62538/ijms-22-02721-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验